{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:34:16Z","timestamp":1762522456946,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ajem.2020.07.029","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T19:11:18Z","timestamp":1595099478000},"page":"541-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Usage analysis of ketorolac in the emergency department"],"prefix":"10.1016","volume":"45","author":[{"given":"Joshua","family":"da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa","family":"Gingras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajem.2020.07.029_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0091270006294597","article-title":"Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers","volume":"47","author":"SD","year":"2007","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ajem.2020.07.029_bb0010","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.27412","article-title":"Variability among nonsteroidal anti-inflammatory medications in risk of upper gastrointestinal bleeding","volume":"62","author":"Masso Gonz\u00e1lez","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ajem.2020.07.029_bb0015","first-page":"139","article-title":"Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management","volume":"53","author":"Gillis","year":"1997","journal-title":"Medications."},{"key":"10.1016\/j.ajem.2020.07.029_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archinte.158.1.33","article-title":"Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory medications, calcium antagonists, and other antihypertensive medications","volume":"158","author":"Rodriguez","year":"1998","journal-title":"Arch Intern Med."},{"issue":"6","key":"10.1016\/j.ajem.2020.07.029_bb0025","first-page":"487","article-title":"Minimising the adverse effects of ketorolac","volume":"22","author":"Reinhart","year":"2000","journal-title":"Medication Saf"},{"key":"10.1016\/j.ajem.2020.07.029_bb0030","first-page":"921","article-title":"Ketorolac, an injectable nonnarcotic analgesic","volume":"9","author":"Litvak","year":"1990","journal-title":"Clin Pharm"},{"issue":"11","key":"10.1016\/j.ajem.2020.07.029_bb0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/j.1552-4604.1989.tb03274.x","article-title":"A double-blind study with placebo control of intramuscular ketorolac tromethamine in the treatment of cancer pain","volume":"29","author":"Staquet","year":"1989","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ajem.2020.07.029_bb0040","first-page":"31244","article-title":"Comparison of intravenous ketorolac at three single-dose regimens for treating acute pain in the emergency department: a randomized controlled trial","volume":"16","author":"Motov","year":"2016","journal-title":"Ann Emerg Med."},{"issue":"1","key":"10.1016\/j.ajem.2020.07.029_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5847\/wjem.j.1920-8642.2017.01.008","article-title":"Patterns of ketorolac dosing by emergency physicians","volume":"8","author":"Soleyman-Zomalan","year":"2017","journal-title":"World J Emerg Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720306227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720306227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:55:41Z","timestamp":1760025341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675720306227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":9,"alternative-id":["S0735675720306227"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2020.07.029","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usage analysis of ketorolac in the emergency department","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2020.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}